Oncology Overview: Safe Use of Oral Tyrosine Kinase Inhibitors in Thoracic OncologyByChristina Billias, PharmD, BCOP August 2nd 2022Pharmacists have the potential to help optimize treatment and maximize supportive care management for targeted therapies.